| 发明名称 |
Cysteine Prodrugs |
| 摘要 |
Novel cysteine prodrugs and their use in the treatment of diseases and/or conditions, including but not limited to diseases and/or conditions of the Central Nervous System (CNS), including but not limited to schizophrenia, drug craving, drug addiction, bipolar disorder, anxiety, depression, Parkinson's disease, Alzheimer's disease, cognitive dysfunction, multiple sclerosis, Amyotrophic lateral sclerosis (ALS), ischemic stroke, HIV dementia, and Huntington's disease. |
| 申请公布号 |
US2016287563(A1) |
申请公布日期 |
2016.10.06 |
| 申请号 |
US201615174410 |
申请日期 |
2016.06.06 |
| 申请人 |
Lawton Daniel;Neary Michael;Nieman James A. |
发明人 |
Lawton Daniel;Neary Michael;Nieman James A. |
| 分类号 |
A61K31/426 |
主分类号 |
A61K31/426 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of treating a disease or condition of the Central Nervous System (CNS) selected from the group consisting of schizophrenia, drug craving, drug addiction, bipolar disorder, anxiety, depression, Parkinson's disease, Alzheimer's disease, cognitive dysfunction, multiple sclerosis, Amyotrophic lateral sclerosis (ALS), ischemic stroke, HIV dementia, and Huntington's disease comprising administering to a subject in need thereof a therapeutically effective amount of a compound of the following formula |
| 地址 |
Bayside WI US |
